Osteoarthritis Trial, Recruiting NCT07347821 Sponsor: Medical University of Warsaw Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07347821
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You are scheduled to have your first-ever knee or hip replacement surgery
  • You have been diagnosed with osteoarthritis (wear-and-tear joint disease) in your hip or knee
  • Enough tissue samples of good quality can be collected from you during the procedure

Who may not be able to join:

  • You have not given written agreement to take part in the study or to have the surgery
  • You have a personal or work-related relationship with the researchers running the trial
  • You have a genetic condition affecting your connective tissue (such as Ehlers-Danlos syndrome or similar) (confirm with trial site)
  • You have a genetic condition affecting your metabolism (such as gout or similar) (confirm with trial site)
  • You have a genetic condition that has changed the normal shape or structure of the joint being operated on (such as dysplasia or similar) (confirm with trial site)
  • You have had a previous surgery that changed the structure of the hip or knee joint being studied (such as certain bone-reshaping or partial joint procedures) (confirm with trial site)
  • You are having a second surgery to fix or replace a previous hip or knee replacement
  • You have a history of an autoimmune disease (where the immune system attacks the body's own tissues)
  • You have had a traumatic injury to the hip or knee joint being treated
  • You have already taken part in this study before

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +48224735218

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medical University of Warsaw
Registry
ClinicalTrials.gov
Start date
22 November 2025
Est. completion
1 December 2027

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Enzymatic activity of selected proteolytic enzymes in periarticular tissue homogenate (e.g., metalloproteinases and selected serine/cysteine proteases).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov